X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5074) 5074
Book Review (1048) 1048
Newsletter (343) 343
Publication (216) 216
Conference Proceeding (24) 24
Newspaper Article (16) 16
Book Chapter (11) 11
Dissertation (5) 5
Trade Publication Article (4) 4
Magazine Article (3) 3
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
olanzapine (4912) 4912
index medicus (3928) 3928
humans (3813) 3813
psychiatry (2945) 2945
schizophrenia (2615) 2615
male (2493) 2493
antipsychotic agents - adverse effects (2405) 2405
female (2359) 2359
antipsychotic agents - therapeutic use (2297) 2297
adult (2026) 2026
risperidone (1704) 1704
schizophrenia - drug therapy (1687) 1687
pharmacology & pharmacy (1666) 1666
middle aged (1424) 1424
double-blind (1206) 1206
clozapine (1156) 1156
haloperidol (1072) 1072
treatment outcome (1024) 1024
neurosciences (945) 945
benzodiazepines - therapeutic use (920) 920
atypical antipsychotics (910) 910
benzodiazepines - adverse effects (899) 899
clinical neurology (879) 879
drug therapy (879) 879
adolescent (769) 769
antipsychotic drugs (769) 769
antipsychotics (762) 762
antipsychotic agents - administration & dosage (738) 738
aged (723) 723
quetiapine (691) 691
drugs (686) 686
psychotropic drugs (664) 664
risperidone - therapeutic use (576) 576
benzodiazepines (568) 568
efficacy (552) 552
risk factors (551) 551
double-blind method (548) 548
bipolar disorder (544) 544
research (542) 542
psychotic disorders - drug therapy (541) 541
psychiatric status rating scales (532) 532
risperidone - adverse effects (508) 508
pirenzepine - analogs & derivatives (507) 507
care and treatment (487) 487
analysis (475) 475
aripiprazole (463) 463
weight gain - drug effects (463) 463
bipolar disorder - drug therapy (461) 461
neuroleptics (450) 450
dose-response relationship, drug (445) 445
dosage and administration (444) 444
complications and side effects (427) 427
young adult (417) 417
placebo (409) 409
drug therapy, combination (391) 391
quetiapine fumarate (390) 390
clinical trials (386) 386
schizophrenic psychology (377) 377
mental disorders (371) 371
animals (363) 363
medicine & public health (360) 360
pirenzepine - adverse effects (359) 359
weight gain (358) 358
antipsychotic agents - pharmacology (347) 347
psychology, clinical (343) 343
time factors (333) 333
risk (326) 326
benzodiazepines - administration & dosage (320) 320
pirenzepine - therapeutic use (320) 320
psychosis (315) 315
clozapine - adverse effects (310) 310
schizoaffective disorder (309) 309
dibenzothiazepines - therapeutic use (303) 303
medical research (303) 303
ziprasidone (302) 302
trial (297) 297
clozapine - therapeutic use (290) 290
retrospective studies (289) 289
body mass index (286) 286
obesity (286) 286
health aspects (282) 282
side effects (281) 281
antipsychotic (280) 280
weight-gain (278) 278
psychopharmacology (277) 277
prevalence (270) 270
placebo-controlled trial (265) 265
randomized controlled trials as topic (264) 264
drug administration schedule (262) 262
medicine, experimental (262) 262
safety (262) 262
prospective studies (258) 258
piperazines - therapeutic use (253) 253
dibenzothiazepines - adverse effects (252) 252
induced weight-gain (250) 250
medicine, general & internal (247) 247
rats (239) 239
follow-up studies (236) 236
severity of illness index (235) 235
schizophrenia - diagnosis (234) 234
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5319) 5319
French (43) 43
German (30) 30
Spanish (26) 26
Portuguese (9) 9
Turkish (8) 8
Chinese (4) 4
Italian (3) 3
Russian (3) 3
Polish (2) 2
Serbian (2) 2
Czech (1) 1
Japanese (1) 1
Korean (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Psychoneuroendocrinology, ISSN 0306-4530, 2017, Volume 81, pp. 138 - 143
Journal Article
Journal Article
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 06/2017, Volume 104, pp. 315 - 325
The present paper discusses the design, characterization and evaluation of glyceryl monostearate nanoparticles of Olanzapine, an atypical antipsychotic drug... 
In vivo study | Olanzapine | Glyceryl monostearate nanoparticles | Box behnken design | Schizophrenia acute phase treatment | Polysorbate 80 coating | FORMULATION DESIGN | DRUG-RELEASE | MODEL | ATYPICAL ANTIPSYCHOTICS | PLGA | PHARMACOKINETICS | SLN | TISSUE DISTRIBUTION | PHARMACOLOGY & PHARMACY | INDUCED WEIGHT-GAIN | BRAIN DELIVERY | Drug Carriers - adverse effects | Surface-Active Agents - adverse effects | Surface-Active Agents - therapeutic use | Drug Carriers - therapeutic use | Nanoparticles - chemistry | Polysorbates - chemistry | Rats, Wistar | Glycerides - adverse effects | Antipsychotic Agents - adverse effects | Drug Carriers - administration & dosage | Delayed-Action Preparations - chemistry | Nanoparticles - adverse effects | Drug Carriers - chemistry | Delayed-Action Preparations - administration & dosage | Antipsychotic Agents - therapeutic use | Nanoparticles - therapeutic use | Drug Compounding | Polysorbates - administration & dosage | Female | Weight Gain - drug effects | Glycerides - chemistry | Polysorbates - adverse effects | Drug Stability | Glycerides - administration & dosage | Polysorbates - therapeutic use | Antipsychotic Agents - administration & dosage | Animals | Antipsychotic Agents - chemistry | Delayed-Action Preparations - adverse effects | Surface-Active Agents - administration & dosage | Benzodiazepines - chemistry | Delayed-Action Preparations - therapeutic use | Drug Liberation | Glycerides - therapeutic use | Benzodiazepines - administration & dosage | Benzodiazepines - adverse effects | Nanoparticles - administration & dosage | Surface-Active Agents - chemistry | Schizophrenia - drug therapy | Benzodiazepines - therapeutic use | Schizophrenia | Complications and side effects | Surface active agents | Analysis | Investigations | Index Medicus
Journal Article
Schizophrenia Research, ISSN 0920-9964, 12/2018, Volume 202, pp. 212 - 216
This study evaluated the ability to flexibly shift cognitive set and to consistently maintain a new response preference using the Penn Conditional Exclusion... 
Psychosis | Antipsychotic | COMT | PCET | DEPRESSION | PSYCHIATRY | RISPERIDONE | PREFRONTAL CORTEX | LESIONS | PHENCYCLIDINE | CATECHOL-O-METHYLTRANSFERASE | DYSFUNCTION | OLANZAPINE | DEFICITS | WORKING-MEMORY | Complications and side effects | Medical colleges | Neurosciences | Catechin | Antipsychotic drugs | Analysis | Transferases | Genetic aspects | Psychophysiology
Journal Article
PHARMACOTHERAPY, ISSN 0277-0008, 10/2013, Volume 33, Issue 10, pp. 1087 - 1106
Journal Article
Journal of Biomedical Nanotechnology, ISSN 1550-7033, 2014, Volume 10, Issue 6, pp. 1137 - 1145
Journal Article
Journal Article
FRONTIERS IN PSYCHIATRY, ISSN 1664-0640, 05/2019, Volume 10, pp. 330 - 330
Objective: Venous thromboembolism (VTE) is a serious multifactorial disorder. Patients with severe mental illness have a higher risk of developing the... 
olanzapine | risk factors | METABOLIC SYNDROME | OBESITY | THROMBOSIS | PSYCHIATRY | venous thromboembolism | antipsychotics | ANTIPSYCHOTIC-DRUGS | side effects | RISK | Medicine, Experimental | Medical research | Dosage and administration | Olanzapine | Thromboembolism | Risk factors
Journal Article